Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complex Partial Seizures”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Large-scale testing (Phase 3)Study completedNCT00433667
What this trial is testing

The Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Who this might be right for
EpilepsyEpilepsy, FocalSeizure Disorder+2 more
SK Life Science, Inc. 563
Large-scale testing (Phase 3)Study completedNCT00310375
What this trial is testing

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Who this might be right for
Epilepsy
GlaxoSmithKline 181
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Large-scale testing (Phase 3)Study completedNCT00425282
What this trial is testing

The Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Who this might be right for
EpilepsyEpilepsy, FocalSeizure Disorder+2 more
SK Life Science, Inc. 566
Large-scale testing (Phase 3)Ended earlyNCT00310388
What this trial is testing

Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097

Who this might be right for
Epilepsy
GlaxoSmithKline 376
Large-scale testing (Phase 3)Study completedNCT00740623
What this trial is testing

The Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 547
Large-scale testing (Phase 3)Study completedNCT01713946
What this trial is testing

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Who this might be right for
Tuberous Sclerosis Complex-associated Refractory Seizures
Novartis Pharmaceuticals 366
Post-approval studies (Phase 4)Study completedNCT01278173
What this trial is testing

The Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Who this might be right for
Adult Refractory Complex Partial Seizures
Lundbeck LLC 65
Not applicableEnded earlyNCT01648959
What this trial is testing

Intra Cranial EEG Activity During Dexmedetomidine Sedation

Who this might be right for
Complex Partial Seizures
University Health Network, Toronto 5
Not applicableStudy completedNCT00044252
What this trial is testing

Role of Hormones in Susceptibility to Seizures in Women With Epilepsy

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 50
Large-scale testing (Phase 3)Study completedNCT00537238
What this trial is testing

Pregabalin Versus Levetiracetam In Partial Seizures

Who this might be right for
Partial Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 509
Testing effectiveness (Phase 2)Study completedNCT02150213
What this trial is testing

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Who this might be right for
Adrenocortical AdenomaEndometrial Stromal Sarcomas
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Post-approval studies (Phase 4)Study completedNCT00537940
What this trial is testing

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Who this might be right for
EpilepsyPartial Seizure DisorderEpilepsies, Partial+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 482
Large-scale testing (Phase 3)Study completedNCT00143143
What this trial is testing

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Who this might be right for
Epilepsies, PartialEpilepsy, Complex Partial
Pfizer 300
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Not applicableStudy completedNCT00001489
What this trial is testing

Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism

Who this might be right for
EpilepsyEpilepsy, Complex Partial
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableLooking for participantsNCT07012148
What this trial is testing

Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

Who this might be right for
Focal EpilepsyGeneralized SeizureDrug Refractory Epilepsy
Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00235755
What this trial is testing

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 539
Next Page